Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Rigel Pharmaceuticals - 25 Year Stock Price History | RIGL

Historical daily share price chart and data for Rigel Pharmaceuticals since 2000 adjusted for splits and dividends. The latest closing stock price for Rigel Pharmaceuticals as of June 23, 2025 is 18.84.
  • The all-time high Rigel Pharmaceuticals stock closing price was 1068.75 on January 03, 2001.
  • The Rigel Pharmaceuticals 52-week high stock price is 29.82, which is 58.3% above the current share price.
  • The Rigel Pharmaceuticals 52-week low stock price is 7.48, which is 60.3% below the current share price.
  • The average Rigel Pharmaceuticals stock price for the last 52 weeks is 17.36.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Rigel Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 19.6453 17.3200 24.3900 16.2500 18.8450 12.04%
2024 13.7357 14.6000 27.8800 7.7300 16.8200 16.00%
2023 12.9002 13.4000 20.0000 7.2240 14.5000 -3.33%
2022 17.3978 27.4000 34.5000 6.7030 15.0000 -43.40%
2021 36.6833 34.7000 49.3000 23.6000 26.5000 -24.29%
2020 23.2289 20.2000 41.2500 12.7000 35.0000 63.55%
2019 21.6518 23.6000 26.5000 16.0000 21.4000 -6.96%
2018 33.4187 39.6000 45.4000 20.8000 23.0000 -40.72%
2017 28.8211 24.9000 43.0000 19.6000 38.8000 63.03%
2016 26.7270 28.6000 40.1000 19.4000 23.8000 -21.45%
2015 31.4659 23.9000 48.7500 20.6000 30.3000 33.48%
2014 29.4388 29.9000 47.5000 16.8000 22.7000 -20.35%
2013 44.4617 67.0000 75.7000 23.5000 28.5000 -56.15%
2012 88.4648 81.9000 112.0000 55.1000 65.0000 -17.62%
2011 77.1054 77.0000 101.5000 65.4000 78.9000 4.78%
2010 80.2703 94.9000 98.3000 63.7000 75.3000 -20.82%
2009 80.6317 78.4000 146.1000 43.3000 95.1000 18.88%
2008 193.6285 246.9000 281.9000 53.8000 80.0000 -68.49%
2007 105.4869 118.9000 274.3000 66.7000 253.9000 113.90%
2006 100.2584 84.6000 121.9000 72.4000 118.7000 41.99%
2005 189.4513 234.4000 245.6000 76.2000 83.6000 -65.77%
2004 209.9108 199.1000 287.2000 111.5000 244.2000 27.19%
2003 104.0465 105.3000 192.0000 52.2000 192.0000 93.76%
2002 259.3768 407.7000 459.0000 94.5900 99.0900 -76.32%
2001 549.0107 1023.7500 1068.7500 292.5000 418.5000 -53.50%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.337B $0.179B
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $84.744B 31.79
Zoetis (ZTS) United States $70.049B 26.14
Takeda Pharmaceutical (TAK) Japan $46.838B 9.32
Daiichi Sankyo, - (DSNKY) Japan $43.381B 22.23
BeOne Medicines - (ONC) Cayman Islands $28.223B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.505B 0.00
Merck (MKKGY) Germany $16.394B 12.01
Summit Therapeutics (SMMT) United States $15.143B 0.00
Shionogi (SGIOY) Japan $14.700B 14.73
United Therapeutics (UTHR) United States $12.918B 11.43
Neurocrine Biosciences (NBIX) United States $12.450B 42.64
Orion OYJ (ORINY) Finland $10.594B 28.65
IPSEN (IPSEY) France $9.607B 0.00
Corcept Therapeutics (CORT) United States $7.877B 64.03
Stevanato Group S.p.A (STVN) Italy $7.099B 43.41
Madrigal Pharmaceuticals (MDGL) United States $6.283B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.996B 0.00
Grifols, S.A (GRFS) Spain $5.755B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.103B 0.00
Hypermarcas (HYPMY) Brazil $2.907B 19.12
Crinetics Pharmaceuticals (CRNX) United States $2.800B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.698B 9.45
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.481B 13.41
BioCryst Pharmaceuticals (BCRX) United States $2.074B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.044B 0.00
Indivior (INDV) United States $1.923B 8.16
Centessa Pharmaceuticals (CNTA) United Kingdom $1.736B 0.00
ARS Pharmaceuticals (SPRY) United States $1.627B 0.00
Endo (NDOI) United States $1.595B 0.00
Evotec AG (EVO) Germany $1.353B 0.00
Ocular Therapeutix (OCUL) United States $1.333B 0.00
Guardian Pharmacy Services (GRDN) United States $1.286B 0.00
Dyne Therapeutics (DYN) United States $1.155B 0.00
Harrow (HROW) United States $1.137B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.058B 21.16
Enliven Therapeutics (ELVN) United States $0.996B 0.00
Verve Therapeutics (VERV) United States $0.990B 0.00
Collegium Pharmaceutical (COLL) United States $0.960B 5.18
Akebia Therapeutics (AKBA) United States $0.956B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.923B 0.00
Ardelyx (ARDX) United States $0.869B 0.00
Elite Pharmaceuticals (ELTP) United States $0.801B 0.00
Xeris Biopharma Holdings (XERS) United States $0.726B 0.00
Cronos Group (CRON) Canada $0.721B 0.00
Xencor (XNCR) United States $0.599B 0.00
KalVista Pharmaceuticals (KALV) United States $0.593B 0.00
Altimmune (ALT) United States $0.567B 0.00
USANA Health Sciences (USNA) United States $0.565B 12.29
Regulus Therapeutics (RGLS) United States $0.564B 0.00
Relay Therapeutics (RLAY) United States $0.554B 0.00
Bioventus (BVS) United States $0.536B 13.58
Theravance Biopharma (TBPH) United States $0.529B 0.00
Liminatus Pharma (LIMN) United States $0.520B 0.00
AleAnna (ANNA) United States $0.504B 0.00
Zevra Therapeutics (ZVRA) United States $0.492B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.442B 9.24
Tourmaline Bio (TRML) United States $0.437B 0.00
Organogenesis (ORGO) United States $0.424B 0.00
Oruka Therapeutics (ORKA) United States $0.408B 0.00
Savara (SVRA) United States $0.373B 0.00
Aquestive Therapeutics (AQST) United States $0.327B 0.00
Heron Therapeutics (HRTX) United States $0.322B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.27
Tonix Pharmaceuticals Holding (TNXP) United States $0.241B 0.00
Nanobiotix S.A (NBTX) France $0.208B 0.00
Esperion Therapeutics (ESPR) United States $0.206B 0.00
MediWound (MDWD) Israel $0.205B 0.00
OmniAb (OABI) United States $0.197B 0.00
Aldeyra Therapeutics (ALDX) United States $0.185B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
ProKidney (PROK) United States $0.177B 0.00
4D Molecular Therapeutics (FDMT) United States $0.175B 0.00
Galectin Therapeutics (GALT) United States $0.157B 0.00
Larimar Therapeutics (LRMR) United States $0.155B 0.00
Aclaris Therapeutics (ACRS) United States $0.151B 0.00
Journey Medical (DERM) United States $0.149B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Avita Medical (RCEL) United States $0.136B 0.00
Achieve Life Sciences (ACHV) Canada $0.133B 0.00
Lyell Immunopharma (LYEL) United States $0.133B 0.00
Lexeo Therapeutics (LXEO) United States $0.131B 0.00
VAXART, INC (VXRT) United States $0.128B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Nektar Therapeutics (NKTR) United States $0.118B 0.00
Champions Oncology (CSBR) United States $0.111B 18.32
Protara Therapeutics (TARA) United States $0.111B 0.00
Korro Bio (KRRO) United States $0.110B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.109B 0.00
Cardiol Therapeutics (CRDL) Canada $0.106B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.097B 0.00
Cassava Sciences (SAVA) United States $0.091B 0.00
Unicycive Therapeutics (UNCY) United States $0.090B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Fractyl Health (GUTS) United States $0.079B 0.00
Surrozen (SRZN) United States $0.077B 0.00
Wellgistics Health (WGRX) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.060B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.059B 43.67
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.054B 0.00
Metagenomi (MGX) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Context Therapeutics (CNTX) United States $0.051B 0.00
Telomir Pharmaceuticals (TELO) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.040B 0.00
Klotho Neurosciences (KLTO) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
FibroGen (FGEN) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Ernexa Therapeutics (ERNA) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Lyra Therapeutics (LYRA) United States $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.16
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Citius Pharmaceuticals (CTXR) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
GlycoMimetics (CBIO) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00